HK Stock MarketDetailed Quotes

JILIN CHANGLONG (08049)

Watchlist
  • 2.350
  • +0.050+2.17%
Trading Mar 27 09:39 CST
1.32BMarket Cap6.56P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

JILIN CHANGLONG (08049) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/H1
Stock NameRevenueRatio
Production and distribution of Chinese medicine and pharmaceutical products438.87M100.00%

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Production and distribution of Chinese medicine and pharmaceutical products438.87M100.00%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
China438.87M100.00%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.06%
Sample Name
Sample Code
 +13.52%
Sample Name
Sample Code
 +10.84%
4
CHINA OILFIELD
02883
-3.27%
5
KUNLUN ENERGY
00135
-11.44%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +10.36%
Sample Name
Sample Code
 +5.32%
Sample Name
Sample Code
 +1.61%
4
Hangzhou Shunwang Technology
300113
-0.92%
5
INESA Intelligent Tech Inc.
600602
-3.22%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -